The mechanosensitive K2P channels TREK1 and TREK2, in co-assembly with K2P TRESK subunits with frameshift mutations implicated in migraine, may also be considered for novel pharmacological interventions acting via unconventional antinociceptive mechanism. The gene discussed is KCNK10; the disease is migraine disorder.